These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6548008

  • 1. [Second tumor following Hodgkin's disease].
    Schmitt K, Tulzer W.
    Padiatr Padol; 1984; 19(3):259-62. PubMed ID: 6548008
    [Abstract] [Full Text] [Related]

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 3. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M, Pianezze G, Fabris P, Cemin S, Coser P.
    Haematologica; 1986 Jun; 71(1):50-2. PubMed ID: 3084357
    [No Abstract] [Full Text] [Related]

  • 6. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E, Schmähl D.
    Neoplasma; 1991 Jun; 38(2):147-55. PubMed ID: 2041574
    [Abstract] [Full Text] [Related]

  • 7. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D, Greenberg M, Fitzgerald A.
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [Abstract] [Full Text] [Related]

  • 8. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 9. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R, Brianzoni F, Leoni P, Danieli G.
    Haematologica; 1993 May 01; 78(4):258-9. PubMed ID: 8294062
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R, Anselmo AP, Osti MF, Santoro M, Tombolini V, Mandelli F, Biagini C.
    Haematologica; 1997 May 01; 82(1):57-63. PubMed ID: 9107084
    [Abstract] [Full Text] [Related]

  • 11. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 12. [Cured from Hodgkin's disease].
    Brice P.
    Bull Cancer; 2002 Jan 15; 89(7-8):666-70. PubMed ID: 12206979
    [Abstract] [Full Text] [Related]

  • 13. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA, Sarma SK, Ahmed Q.
    Bangladesh Med Res Counc Bull; 1982 Dec 15; 8(2):63-7. PubMed ID: 6897860
    [Abstract] [Full Text] [Related]

  • 14. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar 15; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 15. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W, Drzewoski J, Robak T, Krykowski E.
    Kardiol Pol; 1983 Mar 15; 26(7):591-4. PubMed ID: 6689036
    [No Abstract] [Full Text] [Related]

  • 16. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC.
    Br J Cancer; 1999 Oct 15; 81(3):476-83. PubMed ID: 10507773
    [Abstract] [Full Text] [Related]

  • 17. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 Oct 15; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 18. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J, Mauch P, Rosenthal DS, Canellos GP.
    Cancer Treat Rep; 1982 Apr 15; 66(4):1015-22. PubMed ID: 7074629
    [Abstract] [Full Text] [Related]

  • 19. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
    da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, McLaughlin P, Riggs SA, Cabanillas FF, Salvador PG.
    J Clin Oncol; 1984 Jun 15; 2(6):571-7. PubMed ID: 6547167
    [Abstract] [Full Text] [Related]

  • 20. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999 Jun 15; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.